Max Robotics — Global Service Robot Directory + US Certification

About

Yukinori Kurokawa is a surgical oncologist whose research centers on minimally invasive approaches to gastric cancer treatment, with particular emphasis on laparoscopic and robotic-assisted gastrectomy. His work has significantly advanced the evidence base for comparing surgical modalities, most notably through his involvement in the IMIGASTRIC international multi-institutional study, which systematically evaluated robotic, laparoscopic, and open surgery across surgical, clinical, and oncological outcomes. Kurokawa has also played a key role in designing landmark randomized controlled trials, including the JCOG1907 MONA LISA study, a phase III protocol investigating whether robot-assisted gastrectomy can outperform laparoscopic gastrectomy for gastric cancer patients. His contributions extend to perioperative care innovations, including novel reconstruction techniques in proximal gastrectomy and the use of inflammatory biomarkers such as IL-6 and TNF-α for early detection of postoperative complications. His engagement with Japan's National Clinical Database has further enabled population-level insights into surgical trends and the impact of the COVID-19 pandemic on endoscopic surgery. With his most cited works accumulating dozens of citations and influencing international surgical guidelines, Kurokawa stands as an important contributor to the evolving landscape of precision oncological surgery.